These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15992845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Toxicogenomics in biomarker discovery.
    Decristofaro MF, Daniels KK.
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [Abstract] [Full Text] [Related]

  • 4. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):179-88. PubMed ID: 16139318
    [Abstract] [Full Text] [Related]

  • 5. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH, Kienhuis AS, van Ommen B, Stierum RH, Groten JP.
    Expert Rev Proteomics; 2005 Oct 01; 2(5):767-80. PubMed ID: 16209655
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The promise of toxicogenomics.
    Waring JF, Halbert DN.
    Curr Opin Mol Ther; 2002 Jun 01; 4(3):229-35. PubMed ID: 12139308
    [Abstract] [Full Text] [Related]

  • 10. How can toxicogenomics inform risk assessment?
    Oberemm A, Onyon L, Gundert-Remy U.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):592-8. PubMed ID: 15990130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genomic and proteomic applications in diagnosis of platelet disorders and classification.
    Senzel L, Gnatenko DV, Bahou WF.
    Semin Thromb Hemost; 2008 Sep 01; 34(6):532-8. PubMed ID: 19085652
    [Abstract] [Full Text] [Related]

  • 15. OMICS-driven biomarker discovery in nutrition and health.
    Kussmann M, Raymond F, Affolter M.
    J Biotechnol; 2006 Aug 05; 124(4):758-87. PubMed ID: 16600411
    [Abstract] [Full Text] [Related]

  • 16. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
    Merrick BA, London RE, Bushel PR, Grissom SF, Paules RS.
    IARC Sci Publ; 2011 Aug 05; (163):121-42. PubMed ID: 22997859
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA, Orphanides G, Moggs JG.
    Reprod Toxicol; 2005 Aug 05; 20(3):433-40. PubMed ID: 15964738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Integrated expressional analysis: application to the drug discovery process.
    Ilyin SE, Horowitz D, Belkowski SM, Xin H, Eckardt AJ, Darrow AL, Chen C, Maley D, D'Andrea M, Plata-Salamán CR, Derian CK.
    Methods; 2005 Nov 05; 37(3):280-8. PubMed ID: 16308157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.